Locally Advanced Squamous Cell Carcinomas of the Head and Neck (SCCHN)

DBCOND0039701Locally Advanced Head and Neck Cancer Malignant Neoplasms

Locally Advanced Squamous Cell Carcinomas of the Head and Neck (SCCHN) is the indication for 2 drugs in DrugBank. It is covered by 2 curated, structured indications.

Also known as: Locally Advanced Squamous Cell Carcinoma of the Head and Neck (SCCHN)
Classified under: Locally Advanced Head and Neck Cancer
Malignant Neoplasms
Indicated drugs: Cetuximab
Hydroxyurea

What you can answer from here — as of October 22, 2026

2Indicated drugsWith each drug's targets and mechanism

Listed above

2Structured indicationsPopulation, line of therapy, route and combination as fields, not prose

2Clinical trialsPhase, status and sponsor resolved per trial

1Drug reporting it as an adverse effectWith incidence where the label states it

Which approved drugs for Locally Advanced Squamous Cell Carcinomas of the Head and Neck (SCCHN) share a target, and which companies have late-stage candidates against it?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account